TechBio Founders #30:  Developing drug pipelines for life extension and age-related disorders with Ivan De Weber, CEO at Cortex Discovery episode artwork

EPISODE · Mar 20, 2024 · 56 MIN

TechBio Founders #30: Developing drug pipelines for life extension and age-related disorders with Ivan De Weber, CEO at Cortex Discovery

from Next Sequence · host Ivan De Weber, Loretta TIOIELA

Cortex Discovery’s in silico drug discovery platform is based on its leading-edge AI technology which can predict molecule properties in all therapeutic fields. The accuracy of its predictions has been validated in the lab, and rivals that of experiments.

Episode metadata supplied by the publisher feed · Published Mar 20, 2024

Embed this episode

NOW PLAYING

TechBio Founders #30: Developing drug pipelines for life extension and age-related disorders with Ivan De Weber, CEO at Cortex Discovery

0:00 56:07

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Next Sequence?

This episode is 56 minutes long.

When was this Next Sequence episode published?

This episode was published on March 20, 2024.

Can I download this Next Sequence episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!